Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Reis LR, Costa-Rocha IAD, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Costa-Pereira C, Otta DA, Freire LC, Lima SMB, Azevedo AS, Schwarcz WD, Ano Bom APD, Silva AMVD, Souza AF, Castro TDM, Ferroco CLV, Filippis AMB, Nogueira FB, Homma A, Domingues CM, Sousa ESS, Camacho LAB, Maia MLS, Teixeira-Carvalho A, Martins-Filho OA. Reis LR, et al. Vaccine. 2022 Jan 31;40(5):798-810. doi: 10.1016/j.vaccine.2021.12.029. Epub 2021 Dec 27. Vaccine. 2022. PMID: 34969545
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA. da Costa-Rocha IA, et al. Among authors: reis lr. Front Immunol. 2019 Jun 21;10:1211. doi: 10.3389/fimmu.2019.01211. eCollection 2019. Front Immunol. 2019. PMID: 31293563 Free PMC article. Clinical Trial.
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.
Campi-Azevedo AC, Peruhype-Magalhāes V, Coelho-Dos-Reis JG, Antonelli LR, Costa-Pereira C, Speziali E, Reis LR, Lemos JA, Ribeiro JGL, Bastos Camacho LA, de Sousa Maia ML, Barbosa de Lima SM, Simões M, de Menezes Martins R, Homma A, Cota Malaquias LC, Tauil PL, Costa Vasconcelos PF, Martins Romano AP, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine. Campi-Azevedo AC, et al. Among authors: reis lr. Emerg Infect Dis. 2019 Aug;25(8):1511-1521. doi: 10.3201/eid2508.181432. Epub 2019 Aug 17. Emerg Infect Dis. 2019. PMID: 31298654 Free PMC article.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Campi-Azevedo AC, Reis LR, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Antonelli LR, Fonseca CT, Costa-Pereira C, Souza-Fagundes EM, da Costa-Rocha IA, Mambrini JVM, Lemos JAC, Ribeiro JGL, Caldas IR, Camacho LAB, Maia MLS, de Noronha TG, de Lima SMB, Simões M, Freire MDS, Martins RM, Homma A, Tauil PL, Vasconcelos PFC, Romano APM, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA. Campi-Azevedo AC, et al. Among authors: reis lr. Front Immunol. 2019 Sep 26;10:2192. doi: 10.3389/fimmu.2019.02192. eCollection 2019. Front Immunol. 2019. PMID: 31616412 Free PMC article. Clinical Trial.
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA. da Costa-Rocha IA, et al. Among authors: reis lr. Front Immunol. 2019 Oct 22;10:2433. doi: 10.3389/fimmu.2019.02433. eCollection 2019. Front Immunol. 2019. PMID: 31695694 Free PMC article.
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group. Valim V, et al. Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022. Front Immunol. 2022. PMID: 36105814 Free PMC article. Clinical Trial.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Reis LR, Costa-Rocha IA, Abdala-Torres T, Campi-Azevedo AC, Peruhype-Magalhães V, Araújo MSS, Spezialli E, do Valle Antonelli LR, da Silva-Pereira RA, Almeida GG, Fernandes EG, Fantinato FFST, Domingues CMAS, Lemos MCF, Chieppe A, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, de Souza Azevedo A, Schwarcz WD, Camacho LAB, de Lourdes de Sousa Maia M, de Noronha TG, Duault C, Rosenberg-Hasson Y, Teixeira-Carvalho A, Maecker HT, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine. Reis LR, et al. Sci Rep. 2024 Apr 2;14(1):7709. doi: 10.1038/s41598-024-57645-3. Sci Rep. 2024. PMID: 38565882 Free PMC article.
23 results